학술논문

A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials
Document Type
Article
Source
In: Leukemia. (Leukemia, August 2022, 36(8):2022-2031)
Subject
Language
English
ISSN
14765551
08876924